Prot# 265: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Prochymal (Ex-vivo Cultured Adult Human Mesenchymal Stem Cells) Infusion in Combination with Corticosteroids for the Treatment of Newly Diagn

Project: Research project

Project Details

Effective start/end date6/5/086/5/11


  • Quintiles, Inc. (265 // 265)
  • Osiris Therapeutics, Inc. (265 // 265)